- Home
- KYMR vs TFSL Comparison
KYMR vs TFSL Comparison
Compare KYMR & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- TFSL
- Stock Information
- Founded
- KYMR 2015
- TFSL 1938
- Country
- KYMR United States
- TFSL United States
- Employees
- KYMR N/A
- TFSL N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- TFSL Savings Institutions
- Sector
- KYMR Health Care
- TFSL Finance
- Exchange
- KYMR Nasdaq
- TFSL Nasdaq
- Market Cap
- KYMR 3.1B
- TFSL 3.7B
- IPO Year
- KYMR 2020
- TFSL 2007
- Fundamental
- Price
- KYMR $44.64
- TFSL $13.01
- Analyst Decision
- KYMR Strong Buy
- TFSL Hold
- Analyst Count
- KYMR 16
- TFSL 1
- Target Price
- KYMR $58.94
- TFSL $15.00
- AVG Volume (30 Days)
- KYMR 865.2K
- TFSL 392.1K
- Earning Date
- KYMR 08-06-2025
- TFSL 07-29-2025
- Dividend Yield
- KYMR N/A
- TFSL 8.57%
- EPS Growth
- KYMR N/A
- TFSL 0.98
- EPS
- KYMR N/A
- TFSL 0.28
- Revenue
- KYMR $58,885,000.00
- TFSL $304,101,000.00
- Revenue This Year
- KYMR $58.26
- TFSL $0.93
- Revenue Next Year
- KYMR N/A
- TFSL $4.05
- P/E Ratio
- KYMR N/A
- TFSL $46.42
- Revenue Growth
- KYMR N/A
- TFSL 0.00
- 52 Week Low
- KYMR $19.45
- TFSL $11.29
- 52 Week High
- KYMR $53.27
- TFSL $15.00
- Technical
- Relative Strength Index (RSI)
- KYMR 55.84
- TFSL 48.34
- Support Level
- KYMR $43.56
- TFSL $13.22
- Resistance Level
- KYMR $46.34
- TFSL $13.43
- Average True Range (ATR)
- KYMR 1.81
- TFSL 0.20
- MACD
- KYMR -0.60
- TFSL 0.02
- Stochastic Oscillator
- KYMR 36.21
- TFSL 48.08
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.